PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 169 filers reported holding PTC THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $444,000 | +31.4% | 7,267 | +0.6% | 0.00% | 0.0% |
| Q3 2020 | $338,000 | -7.9% | 7,226 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $367,000 | +14.0% | 7,226 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $322,000 | -4.5% | 7,226 | +3.0% | 0.00% | 0.0% |
| Q4 2019 | $337,000 | +42.2% | 7,016 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $237,000 | -25.0% | 7,016 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $316,000 | -14.6% | 7,016 | -28.7% | 0.00% | 0.0% |
| Q1 2019 | $370,000 | +12.8% | 9,834 | +2.9% | 0.00% | 0.0% |
| Q4 2018 | $328,000 | -23.9% | 9,558 | +4.1% | 0.00% | 0.0% |
| Q3 2018 | $431,000 | +81.1% | 9,178 | +30.0% | 0.00% | +100.0% |
| Q2 2018 | $238,000 | +53.5% | 7,060 | -55.3% | 0.00% | 0.0% |
| Q1 2017 | $155,000 | -11.4% | 15,783 | -1.4% | 0.00% | -50.0% |
| Q4 2016 | $175,000 | -2.8% | 16,001 | +24.8% | 0.00% | 0.0% |
| Q3 2016 | $180,000 | +100.0% | 12,817 | -0.2% | 0.00% | +100.0% |
| Q2 2016 | $90,000 | – | 12,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |